Inhibition of Human Lung Cancer Cell Growth by the Peroxisome Proliferator-Activated Receptor-γ Agonists through Induction of Apoptosis
- 1 April 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 270 (2), 400-405
- https://doi.org/10.1006/bbrc.2000.2436
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Medical significance of peroxisome proliferator-activated receptorsThe Lancet, 1999
- The Peroxisome Proliferator-Activated Receptor α (PPARα) Regulates the Plasma Thiobarbituric Acid-Reactive Substance (TBARS) LevelBiochemical and Biophysical Research Communications, 1997
- Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.Endocrinology, 1996
- The nuclear receptor superfamily: The second decadeCell, 1995
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994
- Estimates of the worldwide incidence of eighteen major cancers in 1985International Journal of Cancer, 1993
- Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor.Proceedings of the National Academy of Sciences, 1993
- Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liverFEBS Letters, 1992
- Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)New England Journal of Medicine, 1991
- All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]Blood, 1990